Text size Wall Street Bull Dreamstime This past week was another brutal one for the markets. Investors had plenty to worry about from the Fed to inflation and retail sales. The Dow Jones Industrial Average lost 4.6% last week. It’s fallen 10 of the past 11 weeks and suffered its largest two-week percentage decline since … Read more
Text size Meta Platforms’ advertising business has faced challenges from TikTok and Apple’s privacy changes. David Paul Morris / Bloomberg This year has been brutal for US stocks, but that goes double for high-growth technology stocks. A mix of rising bond yields and recession worries have weighed on the tech sector since late last year. … Read more
The inventory shortage, high prices and rising interest rates have finally bitten. Single-family home sales fell sharply by 16.6% in April to a seasonally adjusted annualized rate of 591,000, according to Census Bureau data released Tuesday. That was the slowest rate of sales since April 2020 during the earliest days of the COVID-19 pandemic, offering … Read more
Text size Deere has earned more than expected for 10 consecutive quarters. Mark Hirsch / Getty Images Deere reported fiscal second-quarter earnings that beat Wall Street expectations. Full-year earnings guidance was raised too. The stock fell anyway on Friday. Deere (ticker: DE) reported earnings per share of $ 6.81 from sales of $ 13.4 billion. … Read more
Cloudflare Inc. shares dropped in the extended session Thursday after the cybersecurity company’s quarterly results slightly beat Wall Street expectations, but its bottom-line forecast for the current quarter indicated a possible miss in its next report. Cloudflare NET, -13.93% shares fell more than 9% after hours, following a 14% drop in the regular session to … Read more
Text size AbbVie stock is up 15.4% so far this year. Courtesy of AbbVie In a quarterly earnings report out Friday, the drugmaker AbbVie cut its full-year earnings guidance, and a number of its key drugs missed Wall Street estimates. The company’s first-quarter earnings were roughly in line with Wall Street expectations. AbbVie (ticker: ABBV) … Read more